My Money is on the Epigenome

It was only two and a half years ago that I was seriously considering paying the $300 to 23andMe to provide an outline of my genetic code. I’m still curious about it but what stopped me at the time was learning that once you consent to the sequencing of your genome, you no longer own that information. It becomes the property of the private company you paid and I didn’t want that this early in the game (the more that I learn about epigenetics the more I wonder if we’re playing the right game anyway).All the same, it saddens me to hear that companies dedicated to ameliorating future pain and illness are having a difficult time in the dog-eat-dog market of pharmaceutical feudalism.